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Background: Drusen are seen in the early and intermediate stages of age-related 
macular degeneration. A retrospective, 2-year observational study at a tertiary centre 
was designed to assess outer nuclear layer thickness in different types of drusen. 
 
Methods: Patients over 50 years with predominant soft drusen or reticular 
pseudodrusen were included in the study. Fundus photography, infrared, fundus 
autofluorescence and spectral domain optical coherence tomography were performed 
at baseline, years 1 and 2. Outer nuclear layer thickness was measured in the nine 
Early Treatment Diabetic Retinopathy Study subfields, and the rate of thinning was 
determined using generalized estimating equations models. 
 
Results: Data were analysed from 17 eyes with soft drusen and 9 eyes with reticular 
pseudodrusen. Greater outer nuclear layer thinning was seen overall and in all 
subfields in reticular pseudodrusen as compared to soft drusen, with statistically 
significant differences found mostly in superior and nasal subfields of ring 2. The outer 
nuclear layer was 5-12 µm thinner in eyes with reticular pseudodrusen, and the rate of 
thinning was greater in eyes with reticular pseudodrusen in the outer superior subfield. 
 
Conclusions: In the present sample, outer nuclear layer thickness was consistently 
lower in patients with reticular pseudodrusen compared with soft drusen, irrespective of 
subfield location. These structural findings may contribute to explain the functional 
abnormalities observed in patients with reticular pseudodrusen. 
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Age-related macular degeneration (AMD) is the leading cause of blindness in people 
over 50 years of age in developed countries.1,2 The pathogenesis of AMD is not entirely 
clear, but drusen are the hallmark signs in the early and intermediate stages of the 
disease.3 In recent years, there has been an improved characterisation of the impact of 
drusen on vision,4-6 and it has been recognized that the degree of functional 
impairment depends on the drusen phenotype7 and its associated features.8  
 
Drusen are known to be deposits of trapped extracellular material lying between the 
basement membrane of the retinal pigment epithelium (RPE) and the inner collagenous 
layer of Bruch’s membrane. They are seen as yellowish, deep lesions into the retina of 
variable size, ranging from 63 µm to more than 250 µm (lesions <63 µm are termed 
drupelets and are not considered to increase the risk of progression to AMD).9 There 
are several types of drusen that are distinguished from each other according to their 
size, topographic distribution in the fundus, location within the retina, and ultrastructural 
composition, which is reflected in the varied appearance on multimodal imaging.10  
 
More relevant from the perspective of conferring an increase in the risk of progression 
towards late AMD are soft drusen and reticular pseudodrusen (RPD, also known as 
subretinal drusenoid deposits,11 reticular macular disease12 or reticular drusen,13 
amongst others). Soft drusen are viewed as bright-round yellowish spots with ill-defined 
margins located under the RPE, and most commonly found at the central macula. In 
contrast, RPD are yellowish white lesions with discrete, interlacing or confluent shape 
located above the RPE in the subretinal space, and with a predilection to involve the 
perifoveal area, mostly in the superior region.14  
 
From a functional point of view, dark adaptometry seems to be worse in eyes with RPD 
than in eyes with soft drusen, with a possible explanation for this being the change in 
photoreceptor function that occurs in the presence of RPD.7 Some authors speculate 
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there is a correlation between the presence of RPD and damage to rods, with cones 
being more resilient than rods to this sort of injury.8  
 
From a structural point of view, RPD evolve through different stages that seem to end 
in outer nuclear layer (ONL) thinning (that is, photoreceptor atrophy) and subsequent 
RPE atrophy.15 The thinning of the ONL is not clinically visible on fundus photography 
or fundus autofluorescence (FAF), but it is identifiable on spectral domain optical 
coherence tomography (SD OCT).15 Also, previous studies have showed ONL 
thickness is significantly reduced in eyes with soft drusen and there is a linear 
relationship between photoreceptor thinning and drusen height.16 Therefore, the 
thickness of the ONL is an important biomarker of progression in retinal degenerations, 
but little is known regarding the longitudinal rate of ONL changes according to drusen 
type.  
 
The purpose of this study was to compare the longitudinal changes in the ONL in 
patients with soft drusen and RPD, in order to gain insights into the structural causes 
which may underpin the functional deficits seen in these patients. 
 
 
METHODS 
Study design 
This was a retrospective, observational study. Patients were selected from those 
attending a tertiary retinal clinic (Institut de la Màcula; Barcelona, Spain) between May 
2009 and February 2017. The study was conducted according to the tenets of the 
Declaration of Helsinki, was approved by the Hospital Quirón Teknon Ethics Committee 
and all patients signed an informed consent. 
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Patient population and eligibility criteria 
This study defined soft drusen as yellowish retinal lesions >63 µm in diameter9 that 
induced an elevation in the RPE on SD OCT. In contrast, RPD were considered 
present when they were seen on infrared or FAF covering an area of at least two disc 
sizes,17 or as elevated subretinal lesions deforming or invading the ellipsoid zone on 
SD OCT. All RPD types (dot, ribbon or peripheral pseudodrusen)18 were eligible. As 
both soft drusen and RPD are commonly present in the same eye,19 eyes were only 
included if one phenotype was clearly predominant over the other according to the 
opinion of two retinal specialists (LF, JM). The predominant drusen type had to involve 
at least three contiguous or non-contiguous Early Treatment Diabetic Retinopathy 
Study (ETDRS) subfields, while the least predominant type could not span more than 
one. 
 
Patients over 50 years old of both genders were included in the study. All patients had 
data for baseline (visit 1), 12±2 months (visit 2) and 24±2 months (visit 3), and either 
predominantly soft drusen or RPD in the study eye (Figure 1).  
 
Patients were excluded from this study if they had, throughout the study period, any 
retinal disease beside soft drusen or RPD that could affect ONL thickness. This 
included specifically prevalent or incident neovascular AMD or geographic atrophy 
(GA), but also retinal dystrophies, a spherical equivalent beyond ±6.00 D, if they 
received intravitreal injections or laser photocoagulation, or if they had undergone any 
type of intraocular surgery, with the exception of phacoemulsification with intraocular 
lens implantation at least 3 months before the study visit. In addition, patients taking 
drugs known to be toxic to the retina (for example, hydroxicloroquine, tamoxifen, 
vigabatrin) and those with poor SD OCT image quality for any reason (media opacities, 
poor cooperation) were also excluded, as eyes with tilted B-scans that allowed 
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visualization of Henle’s fibre layer on one side of the foveola but not the other. Only 
one eye per patient was included; if both eyes were potentially eligible, the study eye 
was randomly chosen. 
 
ONL thickness evaluation 
The ONL was defined on SD OCT as the hyporeflective structure between the 
moderately hypereflective outer plexiform layer and external limiting membrane (ELM) 
in each B-scan of a volumetric scan (Figure 2), and therefore it also included Henle’s 
fibre layer (macular photoreceptor axons) in the thickness measurements. 
Anatomically, the ONL represents the location of the nuclei of photoreceptors.  
 
The thickness of the ONL was measured with the SD OCT Spectralis® (Heidelberg 
Engineering, Heidelberg, Germany), which allows semi-automatic segmentation of 
several retinal layers, included the ONL. Manual correction of segmentation errors was 
performed when required by an experienced observer (CR). Measurements of ONL 
thickness were conducted in each of the nine subfields defined by the ETDRS.20 This 
included one inner circle of 1.0 mm in diameter centred in the foveola, an inner ring of 3 
mm in diameter and an outer ring of 6 mm in diameter. In turn, each ring was further 
divided into four subfields (superior, inferior, nasal, and temporal), resulting in nine 
ETDRS subfields. An average value was provided for each of the nine subfields (Figure 
2) and for the ETDRS circle overall. Eye-tracking software was used to minimise 
motion artefacts during image acquisition and to facilitate rescanning of the macula at 
the same location on follow-up measurements21 taken at years 1 (visit 2) and 2 (visit 3). 
 
The SD OCT protocols used in this study combined FAF or infrared visualisation of the 
fundus with high resolution (1536 x 1536 pixels) B-scans. This was either a 20º 
(horizontal) x 15º (vertical) pattern size (roughly equivalent to 5.8 x 4.3 mm in the 
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fundus) consisting in 19 B-scans equally spaced 240 µm between B-scans, or a 30º x 
15º pattern size (8.7 x 4.3 mm) consisting in 37 B-scans equally spaced 120 µm 
between B-scans. The minimum Automated Real Time rate (averaging) was 9 B-scans 
for all exams.  
Data analysis 
Descriptive statistics were provided for the whole sample and by drusen subgroup (soft 
drusen and RPD) using the mean (standard deviation, SD), median (interquartile 
range, IQR) or percentage as appropriate. Graphical and statistical (Shapiro-Wilk) tests 
for normality of ONL thickness by group and ETDRS subfield were evaluated. Since 
normality could not be assumed, results by group were summarised as median (IQR) 
and non-parametric tests were used (Mann-Whitney or Wilcoxon, as required).  
 
Firstly, differences in ONL thickness between drusen type, by each ETDRS subfield 
(central and nasal, temporal, superior and inferior of inner ring -N1, T1, S1 and I1, 
respectively, and nasal, temporal, superior and inferior of outer ring -N2, T2, S2 and I2, 
respectively) and overall, were determined. This was performed in each period 
(baseline, year 1 and 2). Secondly, longitudinal differences from baseline to year 2 
within drusen subgroup in each subfield and overall were investigated using a paired 
Wilcoxon test. Finally, we tested if there were longitudinal changes in ONL thickness 
between drusen type by period (baseline, years 1 and 2) in each ETDRS subfield and 
overall with an interaction test. For that purpose, we used repeated measures 
generalised estimating equations (GEE) models with an exchangeable working 
correlation and robust standard errors (SEs)22,23, and we estimated the effect of drusen 
type on ONL thickness considering the soft drusen group as the reference. These 
models were adjusted for age.  
8 
 
8 
 
 
To test the intraobserver agreement in manual measurements, five patients were 
randomly selected and measurements of ONL thickness in all B-scans of a given 
volume at a given visit were repeated following the procedure outlined above. The 
results were analysed using Bland-Altman plots.  
 
Data analysis was conducted with Stata/IC 13.1 (StataCorp LP, College Station, TX). A 
two-tailed P-value of <.05 was considered statistically significant. No correction for 
multiple comparisons was made.24  
 
 
RESULTS 
A total of 73 eyes from 73 patients were initially identified with a predominant drusen 
type who did not develop late AMD in the study period (45 with soft drusen and 28 with 
RPD), but only 26 of these patients met the full eligibility criteria with regular yearly 
examinations for two years, and were finally included in the study. There were 17 eyes 
(17/26, 65.4%) with soft drusen and nine eyes (9/26, 34.6%) with RPD. The mean age 
was 72.5 years (SD 8.1 years), 22 were female (22/26, 84.6%), and all were 
Caucasian. Seven of the 26 eyes were right eyes (26.9%). Median best-corrected 
visual acuity (BCVA) was 1.0 (20/20) at baseline (IQR 0) and at year 2 (IQR 0.1). A 
comparison of baseline features between groups is provided in Table 1. Measures of 
ONL thickness showed a high degree of agreement, with an overall mean difference 
between the first and second measurements of less than 1 µm (Figure 3). 
The differences in ONL thickness between soft drusen and RPD are shown in Table 2. 
These results are split according to subfield and time. Median values in Table 2 show 
that ONL thickness was lower in all subfields in RPD compared with soft drusen, with 
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statistically significant results found mostly in subfields of ring 2 (outer sector), where 
RPD are usually located. This is shown graphically in Figure 4. The ONL thickness in 
year 2 was compared with baseline measurements to evaluate the longitudinal trend in 
ONL thinning in soft drusen and RPD (Table 3). Thicknesses in the soft drusen group 
varied slightly, except in the inner superior subfield where they reached statistical 
significance (62 µm vs 56 µm, p=0.03). Progressive ONL thinning seen the RPD group, 
particularly in the nasal and superior subfields (all p≤003). 
 
The longitudinal changes in ONL thickness in the 2-year study period in patients with 
RPD compared with soft drusen (reference group) are shown in Table 4. The results 
are stratified by ETDRS subfield and overall, and are adjusted for age. The values of 
the GEE model show ONL thickness values consistently thinner in the RPD group as 
compared with the soft drusen group (negative coefficient of variable “RPD” in the 
table) in a range between -4.6 µm and -9.7 µm, with an approximate overall decrease 
of 8 µm in eyes of patients with RPD as compared with those with soft drusen. The 
“Visit” variable shows if the change in ONL thickness is more marked in year 1 or 2 of 
follow-up as compared with baseline (regardless of drusen group); overall, it seemed 
slightly more marked in the second year. Of more interest is the “Drusen x visit” 
interaction term, which shows differences in the rate on ONL thickness loss by group 
(soft drusen, RPD) and time (years 1 or 2) that are statistically significant only in the 
second year for the S2 subfield (p<0.001); nonetheless, the negative coefficient for 
most periods (14/18) suggests that the rate of decline is faster for the RPD than for the 
soft drusen group. All these effects were age-independent. 
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DISCUSSION 
The results of the present study revealed that the average ONL thickness across all 
subfields in the ETDRS grid and overall was lower in patients with RPD compared with 
soft drusen. Also, after 2 years of follow-up, the ONL thickness decreased slightly in 
the soft drusen group, but there was an obvious thinning in all regions in eyes with 
RPD, which was statistically significant overall and in the superior, nasal and in the 
foveal region.  
 
Spaide15 reported that areas in which RPD regressed showed a thinning of the ONL 
and coined the term “outer retinal atrophy”, suggesting that this represented an 
unrecognized form of late AMD. The presence of these lesions is a significant fundus 
finding, which not only increases the risk to progression to the classical advanced 
forms of AMD (neovascular AMD and GA),25-27 but also impairs visual function. The 
effects of RPD on vision have been measured using dark adaptometry, where delays in 
rod intercept time were observed (which imply a delayed dark adaptation)7, and by 
microperimetry, where frank28 or modest6 reductions in macular sensitivity were 
encountered. More contradictory results have been found on multifocal 
electroretinography, ranging from no abnormalities29 to delays in implicit time.6 The 
generalised macular ONL thinning found herein could help to explain the structural 
causes underlying the wide range of functional abnormalities found in patients who 
present with drusen. 
 
The damage to photoreceptors (observed by ONL thinning) caused by RPD may be 
explained by either mechanical, toxic or metabolic causes. Physical displacement, 
disruption of the normal photoreceptor or RPE function (possibly related to ocular 
perfusion pressure)30 and/or blockage of the normal diffusion of metabolic activity 
between photoreceptors and the RPE may contribute to photoreceptor degeneration. 
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On the other hand, photoreceptor thinning overlying soft drusen has also been reported 
previously,31 but the lack of a control group in this study precludes comparison of the 
degree of ONL thinning caused by soft drusen with that experienced by age-matched 
healthy individuals. Of note, the changes in SD OCT reflectivity overlying soft drusen, 
initially attributed to a degenerative photoreceptor process, can be explained by optical 
changes in the reflectivity of Henle’s fibre layer due to an increased tilted position 
caused by the elevated drusen.32  
 
 
Two-year changes in unadjusted analyses (Table 3) in the soft drusen group showed a 
trend towards minor thinning, while in the RPD sample consistent small ONL loss was 
seen in all subfields, reaching statistically significant results in the foveal, and nasal 
and superior hemi-fields. While nasal and superior sectors are regions known to 
harbour RPD, the involvement of the fovea is unexpected and suggests a disease that 
spreads beyond the focal location of the lesions. 
 
When the analyses were adjusted for age and interaction terms were added in the 
model to determine if the rate of ONL thinning differed between drusen types (Table 4), 
the only region showing a statistically significant greater ONL loss was the outer 
superior subfield, were RPD are very common. In general, eyes with RPD tended to 
show faster thinning and this tended to increase with time (more marked in year 2 than 
year 1). Nonetheless, results did not reach statistical significance, suggesting sampling 
variability or (more probably) limited power and/or follow-up time to properly address 
this finding. 
 
Of note, there was a marked thinning of the ONL in the fovea despite the fact that RPD 
tend to be rarely seen in this location.17 Similarly, ONL was thinner in RPD compared 
with soft drusen throughout the macular area regardless of the direct presence of RPD 
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lesions in each subfield of the ETDRS grid. These findings suggest RPD may be a 
diffuse disease, not necessarily involving just the areas where RPD is present.4 In 
addition, the magnitude of ONL thinning seen in soft drusen after 2 years was 
approximately 1-2 µm (Table 3), while the difference in ONL thickness between soft 
drusen and RPD was between 5 and 10 µm. This highlights the impact of these 
different lesions on retinal morphology.  
 
ONL thinning progressed despite a stable visual acuity, which suggests this functional 
parameter should not be used to detect ongoing retinal degeneration, especially if RPD 
are present. A multimodal imaging approach that includes SD OCT (and, ideally, FAF 
and/or infrared)33 is therefore required to detect the presence of RPD, and more 
comprehensive psychophysical testing using dark adaptometry and microperimetry34 is 
necessary to monitor the natural course of RPD and its impact on vision and patient 
quality of life. 
 
The main limitations of this study are its retrospective nature, the lack of a healthy 
control group to assess the impact of the presence of each drusen type on ONL 
thickness and the small sample size due to the strict eligibility criteria. As such, this 
should be regarded as an exploratory study. In addition, the SD OCT protocols used in 
this study (19 or 37 B-scans) covered all central, inner, and outer nasal and temporal 
locations in the ETDRS subfields, but only approximately half of the superior and 
inferior subfields in the outer ring. Given this is a more common location for RPD 
compared with soft drusen, the effect (if any) this may have caused is an 
underestimation of the thinning of the ONL caused by RPD in this region, and hence 
our substantive results would have not changed. We also examined global (mean 
subfield ONL thickness) rather than local (changes overlying individual drusen) effects, 
and axial length was not measured, which could have introduced some error in ONL 
thickness measurements. In addition, all ONL measurements include Henle’s fibre 
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layer thickness and therefore they cannot be directly compared with results from 
histology; on the other hand, all included B-scans were acquired horizontally to 
minimize the directional OCT phenomenon,35 and thus comparisons between groups 
and longitudinal differences seem appropriate. For future studies, a prospective design 
will allow capturing this information and allow further exploration of the relationship 
between structural changes and functional performance; also, the inclusion of a group 
with both, soft drusen and RPD, as frequently seen clinically, would allow to draw 
conclusions which are more relevant to patients. A confirmatory study should establish 
the robustness of these results.  
 
In summary, we found the presence of RPD is consistently associated with a thinner 
ONL compared with soft drusen, irrespective of location within the macular area. These 
findings are also observed in the fovea, where soft drusen are common but RPD are 
rarely seen. The rate of thinning was also faster for RPD than for soft drusen in the 
superior outer ring of the ETDRS, a location where RPD are commonly found.  
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Table 1. Comparison of features between groups according to drusen type 
 
 Soft drusen RPD P 
n 17 9 - 
Female (n, %) 14 (82.4) 8 (88.9) 1.00 
Age (SD), years 72.5 (8.6) 72.7 (7.6) 0.95 
BCVA change (IQR), 
decimal 
0 (0.1) 0 (0) 0.37 
Quantitative variables are expressed as mean (SD) or median (IQR) and categorical variables as number (percentage). 
BCVA: best-corrected visual acuity; IQR: interquartile range; RPD: reticular pseudodrusen; SD: standard deviation. 
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Table 2. Comparison of ONL thickness by drusen group. Results are reported as median 
(interquartile range) or mean (SD). All thickness values are in µms.  
 Baseline (visit 1) Year 1 (visit 2) Year 2 (visit 3) 
Location Soft 
drusen 
RPD P Soft 
drusen 
RPD P Soft 
drusen 
RPD P 
Foveal 
91  
(16) 
88 
(7) 
0.07 
93  
(18) 
87 
(16) 
0.08 
90  
(19) 
86 
(12) 
0.08 
N1 
71  
(11) 
68 
(19) 
0.23 
73  
(11) 
67 
(22) 
0.03 
72  
(12) 
61 
(31) 
0.046 
S1 
62  
(11) 
54 
(18) 
0.21 
60  
(7) 
50 
(12) 
0.03 
56  
(20) 
44 
(10) 
0.03 
T1 
70  
(8) 
66 
(11) 
0.29 
67  
(8) 
59 
(10) 
0.23 
68  
(10) 
59 
(12) 
0.12 
I1 
64  
(13) 
57 
(7) 
0.09 
66  
(13) 
56 (8) 
0.04 
63  
(17) 
55 
(13) 
0.29 
N2 
58  
(9) 
50 
(12) 
0.008 
59  
(5) 
50 
(12) 
0.008 
59  
(8) 
48 
(16) 
0.01 
S2 
61  
(12) 
48 
(12) 
0.005 
61  
(6) 
51 
(12) 
0.002 
60  
(11) 
46 
(10) 
0.002 
T2 
58  
(6) 
52 
(9) 
0.01 
58  
(5) 
51 
(10) 
0.07 
59  
(7) 
51  
(8) 
0.01 
I2 
57  
(8.5) 
49 
(10) 
0.02 
57.5 
(7.5) 
47.5 
(9.5) 
0.02 
56.5  
(7) 
46.5 
(11.5) 
0.07 
Overall 
65.3 
(7.1) 
57.6 
(7.3) 
0.016 
64.7 
(7.6) 
55.7 
(7.5) 
0.009 
63.5 
(7.9) 
53.4 
(9.7) 
0.009 
Results are shown by subfield in three periods: at baseline, year 1 and year 2. Values are median (IQR). 1: inner ring; 2: 
outer ring; I: inferior; IQR: interquartile range; N: nasal; ONL: outer nuclear layer; RPD: reticular pseudodrusen; S: superior; 
T: temporal. P-values in bold denote statistical significance. 
21 
 
21 
 
Table 3. Outer nuclear layer (ONL) thickness at baseline compared with year 2. Results 
are reported as median (interquartile range) or mean (SD). All thickness values are in 
µm.  
 
 Soft drusen Reticular pseudodrusen 
Location Baseline Year 2 P Baseline Year 2 P 
Foveal 91 (16) 90 (19) 0.05 88 (7) 86 (12) 0.01 
N1 71 (11) 72 (12) 0.16 68 (19) 61 (31) 0.02 
S1 62 (11) 56 (20) 0.03 54 (18) 44 (10) 0.02 
T1 70 (8) 68 (10) 0.57 66 (11) 59 (12) 0.26 
I1 64 (13) 63 (17) 0.20 57 (7) 55 (13) 0.63 
N2 58 (9) 59 (8) 0.31 50 (12) 48 (16) 0.03 
S2 61 (12) 60 (11) 0.64 48 (12) 46 (10) 0.01 
T2 58 (6) 59 (7) 0.88 52 (9) 51 (8) 0.51 
I2 57 (8.5) 56.5 (7) 0.45 49 (10) 46.5 (11.5) 0.48 
Overall 66.9 (7.7) 63.7 (7.2) 0.07 57.8 (7.3) 55.8 (5.6) 0.008 
Comparisons were made by subfield and overall, separately for patients with soft drusen and reticular pseudodrusen. 
Values represent median (interquartile range). 1: inner ring; 2: outer ring; I: inferior; N: nasal; ONL: outer nuclear layer; S: 
superior; T: temporal. P-values in bold denote statistical significance. 
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Table 4. Effect of drusen type on outer nuclear layer thickness by subfield and overall 
throughout the 2-year period. The significant interaction term “drusen x visit” (p<0.05) 
indicate regions were the rate of change in outer nuclear layer in the study period (in 
years 1 and 2) differs between soft drusen and RPD.  
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Subfield Variables Coefficient Rost SE P 95% CI 
Foveal 
Drusen x visit: 
   RPD x Y1 
   RPD x Y2 
RPD 
Visit: 
   Y1 
   Y2 
Age 
Constant 
 
0.3 
-0.8 
-9.7 
 
-1.3 
-4.8 
-0.02 
95.2 
 
2.5 
3.2 
5.3 
 
1.4 
2.0 
0.05 
4.5 
 
0.91 
0.80 
0.07 
 
0.34 
0.01 
0.57 
<0.001 
 
-4.6 to 5.2 
-7.1 to 5.5 
-20.1 to 0.7 
 
-4.0 to 1.4 
-8.7 to -1.0 
-0.13 to 0.07 
86.5 to 104.0 
N1 
Drusen x visit: 
   RPD x Y1 
   RPD x Y2 
RPD 
Visit: 
   Y1 
   Y2 
Age 
Constant 
 
-4.0 
-4.5 
-7.6 
 
-0.3 
-2.2 
0.23 
53.9 
 
2.5 
2.9 
5.5 
 
1.0 
1.3 
0.05 
4.5 
 
0.11 
0.13 
0.17 
 
0.77 
0.10 
<0.001 
<0.001 
 
-9.0 to 0.9 
-10.2 to 1.3 
-18.3 to 3.2 
 
-2.3 to 1.7 
-4.9 to 0.4 
0.12 to 0.33 
45.0 to 62.8 
S1 
Drusen x visit: 
   RPD x Y1 
   RPD x Y2 
RPD 
Visit: 
   Y1 
   Y2 
Age 
Constant 
 
-2.6 
-3.7 
-6.9 
 
-1.5 
-3.8 
0.05 
56.7 
 
2.9 
2.7 
5.0 
 
1.7 
1.6 
0.05 
4.4 
 
0.38 
0.17 
0.17 
 
0.38 
0.02 
0.27 
<0.001 
 
-8.3 to 3.2 
-9.1 to 1.6 
-16.6 to 2.9 
 
-5.0 to 1.9 
-7.0 to -0.7 
-0.04 to 0.15 
48.1 to 65.4 
T1 
Drusen x visit: 
   RPD x Y1 
   RPD x Y2 
RPD 
Visit: 
   Y1 
   Y2 
Age 
Constant 
 
1.1 
-2.5 
-4.6 
 
-0.9 
0.3 
-0.10 
75.0 
 
2.2 
1.9 
4.0 
 
0.9 
1.4 
0.03 
2.8 
 
0.63 
0.20 
0.25 
 
0.30 
0.83 
<0.001 
<0.001 
 
-3.2 to 5.3 
-6.3 to 1.3 
-12.4 to 3.3 
 
-2.7 to 0.8 
-2.4 to 3.0 
-0.16 to -0.05 
69.6 to 80.5 
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I1 
Drusen x visit: 
   RPD x Y1 
   RPD x Y2 
RPD 
Visit: 
   Y1 
   Y2 
Age 
Constant 
 
-0.8 
-0.4 
-7.9 
 
-0.8 
-2.5 
-0.04 
67.2 
 
2.0 
4.0 
4.4 
 
1.5 
2.2 
0.06 
4.6 
 
0.67 
0.91 
0.07 
 
0.59 
0.27 
0.52 
0.001 
 
-4.7 to 3.0 
-8.4 to 7.5 
-16.6 to 0.8 
 
-3.8 to 2.1 
-6.9 to 1.9 
-0.16 to 0.08 
58.1 to 76.3 
N2 
Drusen x visit: 
   RPD x Y1 
   RPD x Y2 
RPD 
Visit: 
   Y1 
   Y2 
Age 
Constant 
 
-1.9 
-2.2 
-8.7 
 
-0.4 
-0.6 
0.07 
51.4 
 
1.1 
1.4 
3.2 
 
0.8 
0.8 
0.02 
2.2 
 
0.08 
0.1 
0.007 
 
0.68 
0.39 
0.001 
<0.001 
 
-3.9 to 0.2 
-4.9 to 0.4 
-15.0 to -2.3 
 
-2.0 to 1.3 
-2.1 to 0.8 
0.03 to 0.11 
47.1 to 55.7 
S2 
Drusen x visit: 
   RPD x Y1 
   RPD x Y2 
RPD 
Visit: 
   Y1 
   Y2 
Age 
Constant 
 
-3.1 
-5.1 
-9.4 
 
0.9 
-0.6 
0.04 
55.3 
 
1.9 
1.4 
2.9 
 
1.3 
1.0 
0.04 
3.3 
 
0.11 
<0.001 
0.001 
 
0.51 
0.57 
0.25 
<0.001 
 
-6.9 to 0.7 
-7.8 to -2.3 
-15.1 to -3.6 
 
-1.7 to 3.5 
-2.5 to 1.4 
-0.03 to 0.12 
48.7 to 61.8 
T2 
Drusen x visit: 
   RPD x Y1 
   RPD x Y2 
RPD 
Visit: 
   Y1 
   Y2 
Age 
Constant 
 
0.05 
-1.6 
-6.2 
 
-0.5 
0.2 
-0.03 
60.6 
 
0.8 
1.2 
2.3 
 
0.4 
0.6 
0.02 
1.6 
 
0.57 
0.18 
0.007 
 
0.26 
0.72 
0.05 
<0.001 
 
-1.2 to 2.1 
-4.1 to 0.8 
-10.6 to -1.7 
 
-1.3 to 0.3 
-1.0 to 1.5 
-0.06 to 0.00 
57.5 to 63.7 
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I2 
Drusen x visit: 
   RPD x Y1 
   RPD x Y2 
RPD 
Visit: 
   Y1 
   Y2 
Age 
Constant 
 
-0.8 
0.0 
-7.7 
 
0.1 
-0.8 
0.00 
56.6 
 
1.2 
1.6 
3.0 
 
1.0 
0.8 
0.15 
10.6 
 
0.50 
1.00 
0.01 
 
0.95 
0.37 
0.99 
<0.001 
 
-3.2 to 1.6 
-3.1 to 3.1 
-13.6 to -1.9 
 
-1.9 to 2.0 
-2.4 to 0.9 
-0.30 to 0.30 
35.8 to 77.5 
Overall 
Drusen x visit: 
   RPD x Y1 
   RPD x Y2 
RPD 
Visit: 
   Y1 
   Y2 
Age 
Constant 
 
-1.2 
-6.3 
-7.7 
 
-0.6 
-1.7 
0.04 
68.1 
 
0.8 
3.6 
2.8 
 
0.6 
0.8 
0.05 
3.8 
 
0.16 
0.08 
0.007 
 
0.36 
0.02 
0.42 
<0.001 
 
-2.9 to 0.5 
-13.3 to 0.8 
-13.3 to -2.1 
 
-1.8 to 0.7 
-3.2 to -0.2 
-0.14 to 0.06 
60.7 to 75.5 
The RPD group was compared with the soft drusen group (reference group); age in years. 1: inner ring; 2: outer ring; I: 
inferior; CI: confidence interval; N: nasal; RPD: reticular pseudodrusen; S: superior; SE: standard error; T: temporal; Y: 
year. 
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FIGURES 
 
Figure 1. Examples of predominant drusen types. Top, fundus photography, infrared, 
fundus autofluorescence (FAF) and spectral domain optical coherence tomography 
(SD OCT) images, respectively, of a patient with predominantly soft drusen. The retinal 
pigment epithelium (RPE) is elevated on SD OCT due to extracellular deposits located 
between it and Bruch’s membrane. Bottom, corresponding images of a patient with 
predominantly reticular pseudodrusen (RPD). The extracellular deposits are located in 
the subretinal space between the RPE and the photoreceptors. In this image, the RPD 
do not break through the ellipsoid band and are therefore classified as stage 2. 
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Figure 2. Top, example of colour (left) and quantitative (right) maps of the outer 
nuclear layer (ONL) thickness on the nine subfields in the Early Treatment Diabetic 
Retinopathy Study in a patient with reticular pseudodrusen. Notice that part of the 
superior and inferior subfields of the outer ring are not measured. Bottom, B-scan with 
segmented ONL, delimited superiorly by the outer plexiform layer and inferiorly by the 
external limiting membrane. 
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Figure 3. Bland-Altman plot of agreement between repeated first and second ONL 
thickness measurements in a given volume SD OCT at a given visit. The results show 
excellent overall agreement, with a slight tendency to obtain thinner thicknesses upon 
the second measurement. ONL: outer nuclear layer. 
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Figure 4. Longitudinal two-year evolution of outer nuclear layer (ONL) thickness by 
drusen group (solid line for soft drusen, dotted line for reticular pseudodrusen) 
according to their topographic distribution in the Early Treatment Diabetic Retinopathy 
Study grid. 
 
